Trial · NCT00806585
Adverse events170
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 170
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Oedema peripheral | General disorders | MK-0736 0.5 mg | 1 | 137 | 1 |
| other | Oedema peripheral | General disorders | MK-0736 2.0 mg | 2 | 134 | 2 |
| other | Oedema peripheral | General disorders | MK-0736 8.0 mg | 8 | 141 | 10 |
| other | Oedema peripheral | General disorders | HCTZ 12.5 mg → MK-0736 8.0 mg | 2 | 71 | 2 |
| other | Oedema peripheral | General disorders | Placebo | 2 | 137 | 2 |
| other | Nasopharyngitis | Infections and infestations | MK-0736 0.5 mg | 2 | 137 | 2 |
| other | Nasopharyngitis | Infections and infestations | MK-0736 2.0 mg | 8 | 134 | 9 |
| other | Nasopharyngitis | Infections and infestations | MK-0736 8.0 mg | 3 | 141 | 4 |
| other | Nasopharyngitis | Infections and infestations | HCTZ 12.5 mg → MK-0736 8.0 mg | 2 | 71 | 2 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 5 | 137 | 5 |
| other | Upper respiratory tract infection | Infections and infestations | MK-0736 0.5 mg | 8 | 137 | 12 |
| other | Upper respiratory tract infection | Infections and infestations | MK-0736 2.0 mg | 10 | 134 | 17 |
| other | Upper respiratory tract infection | Infections and infestations | MK-0736 8.0 mg | 7 | 141 | 7 |
| other | Upper respiratory tract infection | Infections and infestations | HCTZ 12.5 mg → MK-0736 8.0 mg | 4 | 71 | 5 |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 7 | 137 | 9 |
| other | Low density lipoprotein increased | Investigations | MK-0736 0.5 mg | 9 | 137 | 10 |
| other | Low density lipoprotein increased | Investigations | MK-0736 2.0 mg | 10 | 134 | 10 |
| other | Low density lipoprotein increased | Investigations | MK-0736 8.0 mg | 9 | 141 | 9 |
| other | Low density lipoprotein increased | Investigations | HCTZ 12.5 mg → MK-0736 8.0 mg | 5 | 71 | 5 |
| other | Low density lipoprotein increased | Investigations | Placebo | 4 | 137 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00806585/events